Search results
Freek WA Verheugt
Job title: Professor of Cardiology and Chairman of the Department of Cardiology
Author
Michael H Picard
Job title: Past President
Author
Hector M Garcia-Garcia
Job title: Interventional Cardiologist
Author
Davide Capodanno
Research Area(s) / Expertise:
Job title: Professor of Cardiology and Interventional Cardiologist
Author
Added:
1 year ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan Rance; Special Editor: Greg GuilloryAmerican Heart Association, 18th November 2024 – Plozasiran, an investigational RNA interference (RNAi) therapeutic, has demonstrated significant reductions in triglycerides and acute pancreatitis in patients with Familial Chylomicronemia Syndrome (FCS) in the Phase 3 PALISADE clinical trial (NCT05089084; Arrowhead Pharmeceuticals). The results…
View more
Author(s):
Stephen Nicholls
Added:
7 months ago
ESC Congress 2025 - Pooled MACE Analysis of obicetrapib shows reductions in cardiovascular events and consistent reductions in LDL cholesterol and LP(a).Prof Stephen Nicholls (Monash Victorian Heart Institute, AU) joins us to discuss findings from a pooled major adverse cardiovascular events (MACE) analysis of obicetrapib, examining early signals of cardiovascular benefit in patients with…
View more
A John Camm
Job title: Professor of Clinical Cardiology
Author
Gregory YH Lip
Job title: Professor of Cardiovascular Medicine
Author
Added:
4 months ago
Source:
Radcliffe Vascular
Thoracic aortic aneurysms and dissections (TAADs) are life-threatening conditions with limited pharmacological options, often necessitating high-risk surgical repair.² A key pathological feature is aortic medial degeneration, marked by the accumulation of a glycan-rich matrix. A new study published in the European Heart Journal has identified a metabolic pathway that drives this process,…
View more
Doreen Su-Yin Tan
Job title: Associate Professor, Clinical & Pharmacy Practice
Author